For: | Ghasemi-rad M, Attaya H, Lesha E, Vegh A, Maleki-Miandoab T, Nosair E, Sepehrvand N, Davarian A, Rajebi H, Pakniat A, Fazeli SA, Mohammadi A. Ankylosing spondylitis: A state of the art factual backbone. World J Radiol 2015; 7(9): 236-252 [PMID: 26435775 DOI: 10.4329/wjr.v7.i9.236] |
---|---|
URL: | https://www.wjgnet.com/1949-8470/full/v7/i9/236.htm |
Number | Citing Articles |
1 |
Yuan-Yuan Chen. Correlations of CYP2C9*3/CYP2D6*10/CYP3A5*3 gene polymorphisms with efficacy of etanercept treatment for patients with ankylosing spondylitis. Medicine 2017; 96(9): e5993 doi: 10.1097/MD.0000000000005993
|
2 |
Annalisa Ravani, Fabrizio Vincenzi, Alessandra Bortoluzzi, Melissa Padovan, Silvia Pasquini, Stefania Gessi, Stefania Merighi, Pier Borea, Marcello Govoni, Katia Varani. Role and Function of A2A and A3 Adenosine Receptors in Patients with Ankylosing Spondylitis, Psoriatic Arthritis and Rheumatoid Arthritis. International Journal of Molecular Sciences 2017; 18(4): 697 doi: 10.3390/ijms18040697
|
3 |
Cunyi WANG, Ji'an HU, Jiejun SHI. Role of Interleukin-36 in inflammatory joint diseases. Journal of Zhejiang University (Medical Sciences) 2023; 52(2): 249 doi: 10.3724/zdxbyxb-2023-0034
|
4 |
Renfang Han, Qing Xia, Shengqian Xu, Dazhi Fan, Faming Pan. Interleukin-23 receptor polymorphism (rs10889677 A/C) in ankylosing spondylitis: Meta-analysis in Caucasian and Asian populations. Clinica Chimica Acta 2018; 477: 53 doi: 10.1016/j.cca.2017.11.038
|
5 |
Yuansheng Xu, Wei Jiang, Hui Zhang. Association between C‐reactive protein gene variant and treatment efficacy of etanercept in ankylosing spondylitis patients receiving hip arthroplasty. Journal of Clinical Laboratory Analysis 2020; 34(8) doi: 10.1002/jcla.23343
|
6 |
Dan Huang, Jian Liu, Lei Wan, Yanyan Fang, Yan Long, Ying Zhang, Bingxi Bao. Identification of lncRNAs associated with the pathogenesis of ankylosing spondylitis. BMC Musculoskeletal Disorders 2021; 22(1) doi: 10.1186/s12891-021-04119-6
|
7 |
Yong Ni, Chengrui Jiang. Identification of potential target genes for ankylosing spondylitis treatment. Medicine 2018; 97(8): e9760 doi: 10.1097/MD.0000000000009760
|
8 |
A. Ya. Dimitrenko, V. O. Omelchenko, E. A. Letyagina, M. A. Korolev. Impact of traditional and ankylosing spondylitisassociated risk factors on the formation of atherosclerotic lesions in the brachiocephalic arteries. The Siberian Medical Journal 2020; 35(1): 117 doi: 10.29001/2073-8552-2020-35-1-117-124
|
9 |
Vered Rosenberg, Howard Amital, Gabriel Chodick, Freddy Faccin, Abdulla Watad, Dennis McGonagle, Omer Gendelman. Real-World Adherence and Drug Survival of Biologics among Patients with Ankylosing Spondylitis. Journal of Clinical Medicine 2024; 13(15): 4480 doi: 10.3390/jcm13154480
|
10 |
Jeffrey R. Curtis, Kevin Winthrop, Rhonda L. Bohn, Robert Suruki, Sarah Siegel, Jeffrey L. Stark, Fenglong Xie, Huifeng Yun, Lang Chen, Atul Deodhar. The Annual Diagnostic Prevalence of Ankylosing Spondylitis and Axial Spondyloarthritis in the United States Using Medicare and MarketScan Databases. ACR Open Rheumatology 2021; 3(11): 743 doi: 10.1002/acr2.11316
|
11 |
S.G. Alkhatib, K.A. Shah, K.J. Abrams. Imaging of Calcifying and Ossifying Disorders of the Spine. Neurographics 2021; 11(1): 49 doi: 10.3174/ng.2000051
|
12 |
Jürgen Braun, Xenofon Baraliakos, Atul Deodhar, Dominique Baeten, Joachim Sieper, Paul Emery, Aimee Readie, Ruvie Martin, Shephard Mpofu, Hanno B Richards. Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study. Annals of the Rheumatic Diseases 2017; 76(6): 1070 doi: 10.1136/annrheumdis-2016-209730
|
13 |
Raju Vaishya, Vipul Vijay, Ifeanyi Charles Nwagbara, Amit K. Agarwal. Diffuse idiopathic skeletal hyperostosis (DISH) – A common but less known cause of back pain. Journal of Clinical Orthopaedics and Trauma 2017; 8(2): 191 doi: 10.1016/j.jcot.2016.11.006
|
14 |
Ji-Won Kim, Sunghoon Park, Ju-Yang Jung, Hyoun-Ah Kim, Seong-Ryul Kwon, Sang Tae Choi, Sung-Soo Kim, Sang-Hyeon Kim, Chang-Hee Suh. Prevalence and Factors of Osteoporosis and High Risk of Osteoporotic Fracture in Patients with Ankylosing Spondylitis: A Multicenter Comparative Study of Bone Mineral Density and the Fracture Risk Assessment Tool. Journal of Clinical Medicine 2022; 11(10): 2830 doi: 10.3390/jcm11102830
|
15 |
Joachim Sieper, Atul Deodhar, Helena Marzo-Ortega, Jacob A Aelion, Ricardo Blanco, Tseng Jui-Cheng, Mats Andersson, Brian Porter, Hanno B Richards. Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study. Annals of the Rheumatic Diseases 2017; 76(3): 571 doi: 10.1136/annrheumdis-2016-210023
|
16 |
Omar Larentis, Enrica Tonina, Chiara Tesi, Chiara Rossetti, Ilaria Gorini, Rosagemma Ciliberti, Marta Licata. A probable case of subligamentous tuberculous spondylitis: The concealed body of theLate Modern Period(early 16th century to early 20th century),Franciscancrypt ofSt. AnthonyandSt. Eusebiuschurch,Lombardy,Italy. International Journal of Osteoarchaeology 2020; 30(2): 180 doi: 10.1002/oa.2845
|
17 |
Yongchen Bie, Xiujun Zheng, Xiaojiong Chen, Xiangyun Liu, Liqin Wang, Yuanliang Sun, Jianqiang Kou. RNA sequencing and bioinformatics analysis of differentially expressed genes in the peripheral serum of ankylosing spondylitis patients. Journal of Orthopaedic Surgery and Research 2023; 18(1) doi: 10.1186/s13018-023-03871-w
|
18 |
Adhraa S. Jaber, Ali H. Ad'hiah. A novel signature of interleukins 36α, 37, 38, 39 and 40 in ankylosing spondylitis. Cytokine 2023; 162: 156117 doi: 10.1016/j.cyto.2022.156117
|
19 |
Peter C. Taylor, Désirée van der Heijde, Robert Landewé, Shannon McCue, Sue Cheng, Annelies Boonen. A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing Spondylitis. The Journal of Rheumatology 2021; 48(8): 1259 doi: 10.3899/jrheum.201088
|
20 |
Philip J. Mease, Désirée van der Heijde, Chitra Karki, Mei Liu, Yujin Park, Jeffrey D. Greenberg. Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona Registry. Rheumatology and Therapy 2018; 5(2): 537 doi: 10.1007/s40744-018-0129-z
|
21 |
Christopher S Kovacs. Complex clinical encounter series: osteoporosis presenting during pregnancy and lactation: wait and reassess. Journal of Bone and Mineral Research 2024; 39(3): 197 doi: 10.1093/jbmr/zjae038
|
22 |
Yuliya Pepelyayeva, Andrea Amalfitano. The role of ERAP1 in autoinflammation and autoimmunity. Human Immunology 2019; 80(5): 302 doi: 10.1016/j.humimm.2019.02.013
|
23 |
Chaojie Yu, Xinli Zhan, Tuo Liang, Liyi Chen, Zide Zhang, Jie Jiang, Jiang Xue, Jiarui Chen, Chong Liu. Mechanism of Hip Arthropathy in Ankylosing Spondylitis: Abnormal Myeloperoxidase and Phagosome. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.572592
|
24 |
Masoumeh Mirrahimi, Caroline Ospelt. Fibroblasts - Advances in Inflammation, Autoimmunity and Cancer. Biochemistry 2021; 25 doi: 10.5772/intechopen.100298
|
25 |
Masatoshi YUNOKI, Kenta SUZUKI, Atsuhito UNEDA, Shuichi OKUBO, Koji HIRASHITA, Kimihiro YOSHINO. The Importance of Recognizing Diffuse Idiopathic Skeletal Hyperostosis for Neurosurgeons: A Review. Neurologia medico-chirurgica 2016; 56(8): 510 doi: 10.2176/nmc.ra.2016-0013
|
26 |
Łukasz Jaśkiewicz, Grzegorz Chmielewski, Jakub Kuna, Tomasz Stompór, Magdalena Krajewska-Włodarczyk. The Role of Sclerostin in Rheumatic Diseases: A Review. Journal of Clinical Medicine 2023; 12(19): 6248 doi: 10.3390/jcm12196248
|
27 |
Shigeto Kobayashi, Tomoko Kashiwagi, Junko Kimura. Real-world effectiveness and safety of adalimumab for treatment of ankylosing spondylitis in Japan. Modern Rheumatology 2019; 29(6): 1007 doi: 10.1080/14397595.2018.1525024
|
28 |
Meryem YILMAZ KAYSIN, Ilknur AKTAS, Feyza UNLU OZKAN. A rare case of ankylosing spondylitis with severe temporomandibular joint and dental involvement. Marmara Medical Journal 2017; 30(3): 181 doi: 10.5472/marumj.370860
|